Top Industry Leaders in the HIV Diagnosis Treatment Market
UNAIDS calls for accelerated action The Joint United Nations Programme on HIV/AIDS emphasizes closing the testing and treatment gap in the region, aiming for 95% of people to know their status, 95% on treatment, and 95% virally suppressed by 2030.
ViiV Healthcare partners with local NGOs in South Africa collaborations provide essential support for HIV prevention, testing, and treatment programs.
World Health Organization updates HIV testing recommendations WHO encourages wider use of self-testing and integrated testing for multiple diseases like HIV and syphilis to improve early detection and interventions.
Abbott Laboratories expands access to rapid diagnostic tests in Kenya initiative aims to improve early HIV detection and facilitate timely treatment initiation.
List of Middle East and Africa HIV Diagnosis & Treatment Key Companies in the Market
- Abbott Laboratories (US)
- Boehringer Ingelheim GmbH (Germany)
- Bristol-Myers Squibb Company (US)
- Cipla Inc. (India)
- Hoffmann-La Roche Ltd (Switzerland)
- Gilead (US)
- GlaxoSmithKline plc. (UK)
- Johnson & Johnson Services Inc.(US)
- ViiV Healthcare group of companies (UK)
- Merck & Co. Inc. (US)